HUE043549T2 - Átszerkesztett fenilalanin-ammónia-liáz polipeptidek - Google Patents

Átszerkesztett fenilalanin-ammónia-liáz polipeptidek

Info

Publication number
HUE043549T2
HUE043549T2 HUE14784792A HUE14784792A HUE043549T2 HU E043549 T2 HUE043549 T2 HU E043549T2 HU E14784792 A HUE14784792 A HU E14784792A HU E14784792 A HUE14784792 A HU E14784792A HU E043549 T2 HUE043549 T2 HU E043549T2
Authority
HU
Hungary
Prior art keywords
ammonia lyase
phenylalanine ammonia
engineered phenylalanine
lyase polypeptides
polypeptides
Prior art date
Application number
HUE14784792A
Other languages
English (en)
Inventor
Gjalt Huisman
Nicholas Agard
Benjamin Mijts
Jonathan Vroom
Xiyun Zhang
Original Assignee
Codexis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Codexis Inc filed Critical Codexis Inc
Publication of HUE043549T2 publication Critical patent/HUE043549T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/01Ammonia-lyases (4.3.1)
    • C12Y403/01005Phenylalanine ammonia-lyase (4.3.1.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y403/00Carbon-nitrogen lyases (4.3)
    • C12Y403/01Ammonia-lyases (4.3.1)
    • C12Y403/01024Phenylalanine ammonia-lyase (4.3.1.24)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
HUE14784792A 2013-04-18 2014-04-17 Átszerkesztett fenilalanin-ammónia-liáz polipeptidek HUE043549T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361813586P 2013-04-18 2013-04-18
US201361897932P 2013-10-31 2013-10-31

Publications (1)

Publication Number Publication Date
HUE043549T2 true HUE043549T2 (hu) 2019-08-28

Family

ID=51729192

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE14784792A HUE043549T2 (hu) 2013-04-18 2014-04-17 Átszerkesztett fenilalanin-ammónia-liáz polipeptidek
HUE19163814A HUE055899T2 (hu) 2013-04-18 2014-04-17 Átszerkesztett fenilalanin-ammónia-liáz polipeptidek

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE19163814A HUE055899T2 (hu) 2013-04-18 2014-04-17 Átszerkesztett fenilalanin-ammónia-liáz polipeptidek

Country Status (26)

Country Link
US (17) US9611468B2 (hu)
EP (3) EP3521423B1 (hu)
JP (5) JP6637410B2 (hu)
KR (1) KR102218930B1 (hu)
CN (2) CN109486803B (hu)
AU (2) AU2014253900C1 (hu)
CA (1) CA2909719C (hu)
CY (1) CY1121891T1 (hu)
DK (2) DK2986722T3 (hu)
EA (1) EA034034B1 (hu)
ES (2) ES2890955T3 (hu)
HR (1) HRP20190928T1 (hu)
HU (2) HUE043549T2 (hu)
IL (1) IL242067B (hu)
LT (1) LT2986722T (hu)
MX (1) MX366196B (hu)
MY (1) MY193198A (hu)
NZ (1) NZ713396A (hu)
PE (1) PE20151775A1 (hu)
PH (1) PH12015502412B1 (hu)
PL (1) PL2986722T3 (hu)
PT (1) PT2986722T (hu)
RS (1) RS58802B1 (hu)
SG (1) SG11201508598YA (hu)
SI (1) SI2986722T1 (hu)
WO (1) WO2014172541A2 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2986722T1 (sl) 2013-04-18 2019-07-31 Codexis, Inc. Umetni polipeptidi fenilalanin amonija liaze
EP3928787A1 (en) 2014-04-16 2021-12-29 Codexis, Inc. Engineered tyrosine ammonia lyase
CN106636048A (zh) * 2016-12-14 2017-05-10 江南大学 一株酶活提高的苯丙氨酸脱氨酶突变体
CN106755160B (zh) * 2017-01-17 2019-08-02 湖州颐辉生物科技有限公司 一种组氨酸解氨酶及其用途
KR102573324B1 (ko) 2017-02-13 2023-08-30 코덱시스, 인코포레이티드 조작된 페닐알라닌 암모니아 리아제 폴리펩티드
EP3630795B1 (en) * 2017-05-27 2023-07-26 Enzymaster (Ningbo) Bio-Engineering Co., Ltd. Engineered aldolase polypeptides and uses thereof
EP3807409A4 (en) * 2018-06-12 2022-08-03 Codexis, Inc. MODIFIED TYROSINE AMMONIA-LYASE
CN112672989A (zh) * 2018-07-12 2021-04-16 科德克希思公司 工程化苯丙氨酸氨裂合酶多肽
JP2022512847A (ja) * 2018-10-29 2022-02-07 コデクシス, インコーポレイテッド 操作されたdnaポリメラーゼバリアント
JP2022513199A (ja) 2018-12-14 2022-02-07 コデクシス, インコーポレイテッド 操作されたチロシンアンモニアリアーゼ
BR112022018571A2 (pt) 2020-03-20 2022-11-01 Synlogic Operating Co Inc Microrganismos manipulados para reduzir a hiperfenilalaninemia
EP4271806A1 (en) * 2020-12-31 2023-11-08 Synlogic Operating Company, Inc. Microorganisms engineered to reduce hyperphenylalaninemia
CN114015636B (zh) * 2021-12-08 2023-09-29 天地壹号饮料股份有限公司 重组醋酸菌及其制备方法和应用
CN114457151A (zh) * 2022-01-27 2022-05-10 宁夏医科大学总医院 一种用于检测苯丙氨酸羟化酶基因突变的检测试剂盒及其检测方法
CN117417925A (zh) * 2022-07-18 2024-01-19 浙江泽科塔生物医药有限公司 Pal变体、包含该pal变体的药物组合物以及用于制备该pal变体的方法
CN115518691B (zh) * 2022-10-14 2023-11-21 天津大学 一种具有类漆酶活性的人工酶及制备方法和应用
CN116478975B (zh) * 2023-06-16 2023-09-01 苏州优信合生技术有限公司 高活性苯丙氨酸解氨酶突变体及其表达菌株

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US603344A (en) 1898-05-03 Trough for well-curbs
US753653A (en) 1903-09-14 1904-03-01 American Car & Foundry Co Hopper-bottom car.
DK75593D0 (hu) * 1993-06-25 1993-06-25 Novo Nordisk As
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US6995017B1 (en) 1994-02-17 2006-02-07 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US20060257890A1 (en) 1996-05-20 2006-11-16 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6395547B1 (en) 1994-02-17 2002-05-28 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
DE69523052T2 (de) 1994-06-03 2002-06-20 Novo Nordisk Biotech Inc Gereinigte myceliophthora laccasen und nukleinsäuren dafür kodierend
CN1151762A (zh) 1994-06-30 1997-06-11 诺沃诺尔迪斯克生物技术有限公司 非毒性、非产毒性、非致病性镰孢属表达系统及所用启动子和终止子
FI104465B (fi) 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6506602B1 (en) 1996-03-25 2003-01-14 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US7148054B2 (en) 1997-01-17 2006-12-12 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
IL130635A0 (en) 1997-01-17 2000-06-01 Maxygen Inc Evolution of whole cells and organisms by recursive sequence recombination
AU746786B2 (en) 1997-12-08 2002-05-02 California Institute Of Technology Method for creating polynucleotide and polypeptide sequences
US6365408B1 (en) 1998-06-19 2002-04-02 Maxygen, Inc. Methods of evolving a polynucleotides by mutagenesis and recombination
JP4221100B2 (ja) 1999-01-13 2009-02-12 エルピーダメモリ株式会社 半導体装置
US6917882B2 (en) 1999-01-19 2005-07-12 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
DK1072010T3 (da) 1999-01-19 2010-06-21 Maxygen Inc Oligonukleotidmedieret nukleinsyrerekombination
US6961664B2 (en) 1999-01-19 2005-11-01 Maxygen Methods of populating data structures for use in evolutionary simulations
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7702464B1 (en) 2001-08-21 2010-04-20 Maxygen, Inc. Method and apparatus for codon determining
EP1165757A1 (en) 1999-03-05 2002-01-02 Maxygen, Inc. Encryption of traits using split gene sequences
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US6519065B1 (en) 1999-11-05 2003-02-11 Jds Fitel Inc. Chromatic dispersion compensation device
WO2001075767A2 (en) 2000-03-30 2001-10-11 Maxygen, Inc. In silico cross-over site selection
US6967097B2 (en) 2000-07-24 2005-11-22 Pcbu Services, Inc. Phenylalainine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
US20050084907A1 (en) 2002-03-01 2005-04-21 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
US7747391B2 (en) 2002-03-01 2010-06-29 Maxygen, Inc. Methods, systems, and software for identifying functional biomolecules
EP2278509B1 (en) 2002-03-01 2014-11-19 Codexis Mayflower Holdings, LLC Methods, systems, and software for identifying functional biomolecules
JP4851687B2 (ja) 2002-03-09 2012-01-11 マキシジェン, インコーポレイテッド 定向進化のための交叉点の最適化
US8003356B2 (en) 2004-04-20 2011-08-23 E. I. Du Pont De Nemours And Company Methods for the preparation of para-hydroxycinnamic acid and cinnamic acid at alkaline pH
US7553653B2 (en) 2004-09-17 2009-06-30 Biomarin Pharmaceutical Inc. Variants and chemically-modified variants of phenylalanine ammonia-lyase
EP2886658A1 (en) 2005-03-10 2015-06-24 BASF Enzymes LLC Lyase enzymes, nucleic acids encoding them and methods for making and using them
US7534595B2 (en) * 2006-06-12 2009-05-19 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7531341B1 (en) 2006-06-12 2009-05-12 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
WO2008069958A2 (en) * 2006-12-01 2008-06-12 The Salk Institute For Biological Studies Substrate switched ammonia lyases and mutases
US7537923B2 (en) 2007-08-17 2009-05-26 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
DK3023494T3 (en) 2008-06-13 2019-02-25 Codexis Inc PROCEDURE FOR SYNTHESIS OF POLYNUCLEOTIDE VARIETIES
US20090312196A1 (en) 2008-06-13 2009-12-17 Codexis, Inc. Method of synthesizing polynucleotide variants
US8383346B2 (en) 2008-06-13 2013-02-26 Codexis, Inc. Combined automated parallel synthesis of polynucleotide variants
JP5828844B2 (ja) 2010-02-04 2015-12-09 ビオマリン プハルマセウトイカル インコーポレイテッド 原核生物フェニルアラニンアンモニアリアーゼ変異体の組成物、及び、その組成物を用いる方法
CA2815341A1 (en) 2010-11-05 2012-05-10 Basf Plant Science Company Gmbh Methods for increasing yield and fine chemical production in plants
US9150884B2 (en) 2011-03-08 2015-10-06 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Microbial conversion of glucose to styrene and its derivatives
WO2012178126A1 (en) 2011-06-23 2012-12-27 Phytogene, Inc. Enzymatic system for monomer synthesis
SI2986722T1 (sl) 2013-04-18 2019-07-31 Codexis, Inc. Umetni polipeptidi fenilalanin amonija liaze

Also Published As

Publication number Publication date
ES2890955T3 (es) 2022-01-25
US20180016568A1 (en) 2018-01-18
US20190055535A1 (en) 2019-02-21
MX366196B (es) 2019-07-01
EP3521423A1 (en) 2019-08-07
US10358639B2 (en) 2019-07-23
EP2986722A4 (en) 2017-02-22
HRP20190928T1 (hr) 2019-07-26
AU2019272057B2 (en) 2021-05-27
AU2014253900A1 (en) 2015-11-12
US20190040377A1 (en) 2019-02-07
EP3521423B1 (en) 2021-07-21
WO2014172541A3 (en) 2015-02-19
EP2986722A2 (en) 2016-02-24
US10870843B2 (en) 2020-12-22
KR102218930B1 (ko) 2021-02-23
US11130947B2 (en) 2021-09-28
PT2986722T (pt) 2019-06-21
US10294468B2 (en) 2019-05-21
CN109486803A (zh) 2019-03-19
US10144924B2 (en) 2018-12-04
CY1121891T1 (el) 2020-10-14
US10160963B2 (en) 2018-12-25
US11401515B2 (en) 2022-08-02
US20180037880A1 (en) 2018-02-08
US10487319B2 (en) 2019-11-26
PH12015502412A1 (en) 2016-02-22
US20190241882A1 (en) 2019-08-08
LT2986722T (lt) 2019-09-10
US20200399627A1 (en) 2020-12-24
US20190055536A1 (en) 2019-02-21
CN109486803B (zh) 2022-10-25
JP2016516428A (ja) 2016-06-09
CN105324483B (zh) 2018-11-30
CA2909719A1 (en) 2014-10-23
JP2020185016A (ja) 2020-11-19
US20200231959A1 (en) 2020-07-23
MX2015014662A (es) 2016-03-03
EA034034B1 (ru) 2019-12-20
US11913045B2 (en) 2024-02-27
US20140314843A1 (en) 2014-10-23
JP2020185017A (ja) 2020-11-19
EP3971288A1 (en) 2022-03-23
KR20150143816A (ko) 2015-12-23
AU2019272057A1 (en) 2019-12-19
RS58802B1 (sr) 2019-07-31
DK3521423T3 (da) 2021-09-06
US10975367B2 (en) 2021-04-13
CA2909719C (en) 2022-09-27
PE20151775A1 (es) 2015-12-02
AU2014253900C1 (en) 2020-04-02
US20200032233A1 (en) 2020-01-30
US20200199566A1 (en) 2020-06-25
SG11201508598YA (en) 2015-11-27
JP7129715B2 (ja) 2022-09-02
US20210222146A1 (en) 2021-07-22
IL242067B (en) 2018-03-29
JP2018166524A (ja) 2018-11-01
US10717974B2 (en) 2020-07-21
EA201591995A1 (ru) 2016-04-29
MY193198A (en) 2022-09-26
US9611468B2 (en) 2017-04-04
US10640759B2 (en) 2020-05-05
ES2729048T3 (es) 2019-10-30
SI2986722T1 (sl) 2019-07-31
DK2986722T3 (da) 2019-05-13
EP2986722B1 (en) 2019-04-03
US20200040325A1 (en) 2020-02-06
JP2022183356A (ja) 2022-12-08
AU2014253900B2 (en) 2019-09-19
US20200032236A1 (en) 2020-01-30
NZ713396A (en) 2020-06-26
CN105324483A (zh) 2016-02-10
JP6637410B2 (ja) 2020-01-29
PH12015502412B1 (en) 2016-02-22
PL2986722T3 (pl) 2019-10-31
US10494623B2 (en) 2019-12-03
US20200032235A1 (en) 2020-01-30
WO2014172541A2 (en) 2014-10-23
US11136571B2 (en) 2021-10-05
BR112015026160A2 (pt) 2017-10-10
US20170191050A1 (en) 2017-07-06
US20200032234A1 (en) 2020-01-30
US10941391B2 (en) 2021-03-09
HUE055899T2 (hu) 2022-01-28

Similar Documents

Publication Publication Date Title
IL242067B (en) Transgenic phenylalanine ammonia lyase polypeptides
HK1216757A1 (zh) 肽化合物
HRP20180452T1 (hr) Peptidi
PL3061771T3 (pl) Nowy peptyd o czterech połączonych epitopach dla ctl
IL268226A (en) Phenylalanine ammonia lyase engineered polypeptides
HK1211596A1 (en) Peptide
HK1211595A1 (en) Peptide
GB201315130D0 (en) Peptides
AU353152S (en) Limestone block
AU353153S (en) Limestone block
AU353156S (en) Limestone block
AU353155S (en) Limestone block
AU353154S (en) Limestone block
AU353151S (en) Limestone block
GB201316660D0 (en) Peptides
GB201305465D0 (en) Novel peptides
GB201300381D0 (en) Peptides